Published in Paediatr Child Health on June 01, 2013
Diagnosis and management of acute otitis media. Pediatrics (2004) 7.80
Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis (1993) 3.68
A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis (1997) 3.50
Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics (2011) 2.45
Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother (2002) 2.30
Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clin Infect Dis (2000) 1.89
Hidden epidemic of macrolide-resistant pneumococci. Emerg Infect Dis (2005) 1.68
Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J (2000) 1.57
Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption? J Chemother (1999) 1.55
Large dosage amoxicillin/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children. Pediatr Infect Dis J (2005) 1.49
Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin Infect Dis (2006) 1.34
Appropriate antibiotic use and why it is important: the challenges of bacterial resistance. Pediatr Infect Dis J (2003) 1.31
Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4. Ann Clin Microbiol Antimicrob (2008) 1.29
Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob Agents Chemother (2000) 1.28
Antibiotic use among children in British Columbia, Canada. J Antimicrob Chemother (2006) 1.27
Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14. J Antimicrob Chemother (2004) 1.21
Pneumonia in healthy Canadian children and youth: Practice points for management. Paediatr Child Health (2011) 1.19
Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin. Clin Infect Dis (2000) 1.09
A comparison of antibiotic use in children between Canada and Denmark. Ann Pharmacother (2007) 1.00
Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis. Ther Drug Monit (2006) 0.98
Pharmacokinetics of azithromycin after single- and multiple-doses in children. Pharmacotherapy (1997) 0.93
Resistance phenotypes and multi-drug resistance in Streptococcus pneumoniae (PROTEKT years 1-3 [1999-20021). J Chemother (2004) 0.84
Invasive pneumococcal disease after implementation of a reduced three-dose pneumococcal conjugate vaccine program: a pediatric tertiary care center experience. Eur J Pediatr (2010) 0.84
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nat Genet (2009) 3.83
Effectiveness and tolerability of pharmacologic and combined interventions for reducing injection pain during routine childhood immunizations: systematic review and meta-analyses. Clin Ther (2009) 2.00
Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol (2011) 1.62
Inadequate pain management during routine childhood immunizations: the nerve of it. Clin Ther (2009) 1.51
Palatability, adherence and prescribing patterns of antiretroviral drugs for children with human immunodeficiency virus infection in Canada. Pharmacoepidemiol Drug Saf (2011) 1.42
The rise of the rats: A growing paediatric issue. Paediatr Child Health (2010) 1.12
Life-threatening flecainide intoxication in a young child secondary to medication error. Ann Pharmacother (2009) 1.12
Translational research in pediatrics: tissue sampling and biobanking. Pediatrics (2011) 1.05
Bronchiolitis: Recommendations for diagnosis, monitoring and management of children one to 24 months of age. Paediatr Child Health (2014) 1.00
A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Popul Ther Clin Pharmacol (2011) 0.99
Bordetella holmesii bacteremia in asplenic children: report of four cases initially misidentified as Acinetobacter lwoffii. J Clin Microbiol (2010) 0.99
Rhinoscleroma: a French national retrospective study of epidemiological and clinical features. Clin Infect Dis (2008) 0.99
Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation. Biol Blood Marrow Transplant (2008) 0.99
Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells: influence of HIV infection on clindamycin toxicity in vitro. J Clin Pharmacol (2005) 0.98
"But I see old people everywhere": dispelling the myth that eldercare is learned in nongeriatric clerkships. Acad Med (2010) 0.97
Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling. J Immunol (2007) 0.96
Fatal group A Streptococcus purpura fulminans in a child receiving TNF-α blocker. Eur J Pediatr (2010) 0.96
The trials and tribulations of doing drug research in children. CMAJ (2003) 0.95
Severe bullous hypersensitivity reactions after exposure to carbamazepine in a Han-Chinese child with a positive HLA-B*1502 and negative in vitro toxicity assays: evidence for different pathophysiological mechanisms. J Popul Ther Clin Pharmacol (2011) 0.95
An algorithm to detect adverse drug reactions in the neonatal intensive care unit. J Clin Pharmacol (2013) 0.92
Systemic capillary leak syndrome presenting as recurrent shock. Pediatr Crit Care Med (2006) 0.92
The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology. Thyroid (2010) 0.92
Novel influenza A (H1N1): clinical features of pediatric hospitalizations in two successive waves. Int J Infect Dis (2010) 0.91
Drug research and treatment for children in Canada: A challenge. Paediatr Child Health (2011) 0.91
Clinical and microbiologic characteristics of group A streptococcal necrotizing fasciitis in children. Pediatr Infect Dis J (2009) 0.91
Compliance assessment in drug trials: has there been improvement in two decades? Can J Clin Pharmacol (2005) 0.89
Treating cough and cold: Guidance for caregivers of children and youth. Paediatr Child Health (2011) 0.89
A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk. PLoS One (2013) 0.89
Acetaminophen overdose in children. CMAJ (2012) 0.88
Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Ann Pharmacother (2007) 0.88
The predictive value of the in vitro platelet toxicity assay (iPTA) for the diagnosis of hypersensitivity reactions to sulfonamides. J Clin Pharmacol (2013) 0.88
A palatability study of a flavored dexamethasone preparation versus prednisolone liquid in children. Can J Clin Pharmacol (2008) 0.86
Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions. Epilepsia (2014) 0.86
Evaluation of streptococcal clinical scores, rapid antigen detection tests and cultures for childhood pharyngitis. Eur J Pediatr (2004) 0.85
Tuberculosis in adolescents: A French retrospective study of 52 cases. Pediatr Infect Dis J (2006) 0.85
Fatal disseminated Trichosporon asahii infection in a child with acute lymphoblastic leukemia. Can J Infect Dis Med Microbiol (2008) 0.85
Invasive pneumococcal disease after implementation of a reduced three-dose pneumococcal conjugate vaccine program: a pediatric tertiary care center experience. Eur J Pediatr (2010) 0.84
Cutaneous adverse drug reactions in children: an analysis of reports from the Canadian Pharmacogenomics Network for Drug Safety (CPNDS). J Popul Ther Clin Pharmacol (2011) 0.84
Rural women and pharmacologic therapy: needs and issues in rural Canada. Can J Rural Med (2008) 0.84
Women and pharmacologic therapy in rural and remote Canada. Can J Rural Med (2006) 0.83
Haptenation of sulfonamide reactive metabolites to cellular proteins. Mol Pharmacol (2002) 0.83
Relationship between antiepileptic drugs and biological markers affecting long-term cardiovascular function in children and adolescents. Can J Clin Pharmacol (2010) 0.83
The in vitro platelet toxicity assay (iPTA): a novel approach for assessment of drug hypersensitivity syndrome. J Clin Pharmacol (2010) 0.83
Human hair cortisol analysis: comparison of the internationally-reported ELISA methods. Clin Invest Med (2013) 0.83
Evaluation of several approaches to immunize parents of neonates against B. pertussis. Vaccine (2013) 0.83
Evaluation of a school-based program for diagnosis and treatment of latent tuberculosis infection in immigrant children. J Infect Public Health (2010) 0.82
Hypersensitivity of HIV-1-infected cells to reactive sulfonamide metabolites correlated to expression of the HIV-1 viral protein tat. J Pharmacol Exp Ther (2005) 0.82
Assessment of the palatability of vehicles for activated charcoal in pediatric volunteers. Pediatr Emerg Care (2002) 0.81
Where physicians look for information on drug prescribing for children. Paediatr Child Health (2003) 0.81
Group A streptococcal meningitis in a pediatric patient following cochlear implantation: report of the first case and review of the literature. J Clin Microbiol (2005) 0.81
Lymphomatoid granulomatosis: a unique complication of Crohn disease and its treatment in pediatrics. J Pediatr Gastroenterol Nutr (2010) 0.80
Self-reported experience and competence in core procedures among Canadian pediatric emergency medicine fellowship trainees. CJEM (2008) 0.80
Low systemic ganciclovir exposure and preemptive treatment failure of cytomegalovirus reactivation in a transplanted child. J Popul Ther Clin Pharmacol (2011) 0.79
Increased adverse drug reactions to antimicrobials and anticonvulsants in patients with HIV infection. Ann Pharmacother (2006) 0.79
N-acetylcysteine rescue protocol for nephrotoxicity in children caused by ifosfamide. J Popul Ther Clin Pharmacol (2013) 0.79
Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation. J Immunol (2012) 0.78
A surveillance method for the early identification of idiosyncratic adverse drug reactions. Drug Saf (2008) 0.78
Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients? Pediatr Pulmonol (2010) 0.78
Halofantrine efficacy in non-immune children with imported acute Plasmodium falciparum malaria Infection. Eur J Pediatr (2003) 0.78
Oral morphine weaning for neonatal abstinence syndrome at home compared with in-hospital: an observational cohort study. Paediatr Drugs (2015) 0.78
N-acetylcysteine as a novel prophylactic treatment for ifosfamide-induced nephrotoxicity in children: translational pharmacokinetics. J Clin Pharmacol (2011) 0.77
Pharmacogenetics and beyond: variability of voriconazole plasma levels in a patient with primary immunodeficiency. Pharmacogenomics (2012) 0.77
Adverse drug reactions to protease inhibitors. Can J Clin Pharmacol (2002) 0.77
Pharmacokinetics of prednisolone at steady state in young patients with systemic lupus erythematosus on prednisone therapy: an open-label, single-dose study. Clin Ther (2011) 0.77
Toxicity of a traditional Chinese medicine, Ganoderma lucidum, in children with cancer. Can J Clin Pharmacol (2008) 0.77
Pharmacokinetic studies in infants using minimal-risk study designs. Curr Clin Pharmacol (2014) 0.77
Are infants exposed to methadone in utero at an increased risk for mortality? J Popul Ther Clin Pharmacol (2012) 0.77
Fatal cases of Staphylococcus aureus pleural empyema in infants. Pediatr Dev Pathol (2009) 0.77
Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Drug Saf (2009) 0.76
Predictive value of the lymphocyte toxicity assay in the diagnosis of drug hypersensitivity syndrome. Mol Diagn Ther (2010) 0.76
In vitro testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Mol Diagn Ther (2009) 0.76
Statins, indication creep and risks for children and youth. CMAJ (2008) 0.76
Is the medical use of cannabis a therapeutic option for children? Paediatr Child Health (2016) 0.75
Paediatrician human resource planning in Canada: A 10-year follow-up. Paediatr Child Health (2005) 0.75
Folate and neural tube defects: The role of supplements and food fortification. Paediatr Child Health (2016) 0.75
A survey of Canadian medical student attitudes towards the ethics of pediatric clinical trials: are they different from Canadian and British health care professionals? J Popul Ther Clin Pharmacol (2011) 0.75
Invasive group A Streptococcus disease in French-Canadian children is not associated with a defect in MyD88/IRAK4-pathway. Allergy Asthma Clin Immunol (2014) 0.75
Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology (2002) 0.75
What is the risk of using a cephalosporin in a patient with a penicillin allergy? Paediatr Child Health (2007) 0.75
Adderall and cardiovascular risk: A therapeutic dilemma. Paediatr Child Health (2009) 0.75
Counseling regarding pregnancy--related drug exposures by family physicians in Ontario. Can J Clin Pharmacol (2007) 0.75
Variations in the management of pneumonia in pediatric emergency departments: compliance with the guidelines. CJEM (2010) 0.75
Pharmacokinetic profile of valganciclovir in pediatric transplant recipients. Pediatr Infect Dis J (2012) 0.75
Serum sickness-like reaction possibly associated with meropenem use. Clin Infect Dis (2003) 0.75
Pharmacokinetics and pharmacodynamics of oral cephalexin in children with osteoarticular infections. Pediatr Infect Dis J (2013) 0.75
Syphilis Infection: An Uncommon Etiology of Infectious Nonimmune Fetal Hydrops with Anemia. Fetal Diagn Ther (2014) 0.75
Hair cortisol as a biomarker of stress in the 2011 Libyan war. Clin Invest Med (2014) 0.75
Young children's perceptions of physicians wearing standard precautions versus customary attire. Pediatr Emerg Care (2006) 0.75
Calcineurin inhibitor-free graft-versus-host disease prophylaxis with sirolimus and mycophenolate mofetil in a second allogeneic stem cell transplantation for engraftment failure and rituximab-refractory Epstein-Barr virus-induced posttransplant lymphoproliferative disease. J Pediatr Hematol Oncol (2014) 0.75
Posaconazole Plasma Monitoring in Immunocompromised Children. J Pediatric Infect Dis Soc (2017) 0.75